Aethlon Medical
AEMD
10 hedge funds and large institutions have $114K invested in Aethlon Medical in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 11 closing their positions.
0.02% more ownership
Funds ownership: 0% → 0.03% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
33% less capital invested
Capital invested by funds: $171K → $114K (-$56.7K)
52% less funds holding
Funds holding: 21 → 10 (-11)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.84K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$427 |
| 3 |
Morgan Stanley
New York
|
+$142 |
Top Sellers
AEMD Hedge Fund Activity: Q4 2023 in Review
10 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2023, worth a combined $114K — down 33% from $171K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AEMD and 0 opened new positions — a net loss of 11 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $3.84K. The largest seller was Allegiance Financial Group Advisory Services, exiting entirely with an estimated $11.3K sold.
- 10 institutional investors held Aethlon Medical (AEMD) as of Q4 2023, down from 21 in Q3 2023.
- Funds reported $114K of Aethlon Medical stock for Q4 2023, down 33% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q4 2023 and 11 closed out, a net change of -11 holders.
- The largest Aethlon Medical buyer in Q4 2023 was Vanguard Group, an estimated $3.84K added.
- The largest Aethlon Medical seller in Q4 2023 was Allegiance Financial Group Advisory Services, an estimated $11.3K sold.
Based on aggregated 13F filings for Q4 2023.